Private
Operation Warp Speed, the White House-created program to speed up COVID-19 vaccine candidate development and manufacturing domestically, will benefit from a $628 million expansion of an existing public-private partnership with Emergent BioSolutions Inc., the U.S. Department of Health and Human... Read More »
A phase 3 clinical trial that will utilize a mix of Actemra/RoActemra and remdesivir on hospitalized COVID-19 patients with severe pneumonia is expected to begin in June, as part of a collaboration between Roche and Gilead Sciences, Inc.
That trial, REMDACTA, will be double-blind, randomized,... Read More »
GlaxoSmithKline (GSK) said it will manufacture 1 billion doses of its pandemic vaccine adjuvant system in 2021 to support the development of multiple adjuvanted COVID-19 vaccine candidates.
The pharmaceutical company says its pandemic adjuvant technology could make a significant contribution... Read More »
A new reference panel being offered by the U.S. Food and Drug Administration (FDA) proposes an additional, independent validation step to guarantee the quality of COVID-19 diagnostic tests.
Since COVID-19 reached U.S. shores earlier this year, many tests have arisen to detect its viral cause:... Read More »
Recent findings from a NORC at the University of Chicago study have determined if a COVID-19 vaccine becomes available, 49 percent of respondents said they plan to get vaccinated.
The nationwide poll was conducted May 14-18, 2020, via the AmeriSpeak Panel - the probability-based panel of NORC at... Read More »
Merck announced a series of actions against COVID-19 this week, joining the fight against the global pandemic through two agreements that further potential vaccines against its viral source, SARS-CoV-2, and a research collaboration intended to create a novel antiviral candidate.
“With our... Read More »
A COVID-19 vaccine candidate created by Novavax, Inc. and supported by the Coalition for Epidemic Preparedness Innovations (CEPI) began clinical trials this week, with the enrollment of participants in a Phase 1/2 study.
The vaccine in question is called NVX-CoV2373, a stable, prefusion protein... Read More »
Social media companies need to step up and use the technology they already have to limit extremist groups from spreading misinformation and conspiracy theories online, experts said Wednesday during a U.S. House Homeland Security Committee virtual forum on extremism during the COVID-19 pandemic.... Read More »
A preliminary report on data from the Adaptive COVID-19 Treatment Trial, published in the New England Journal of Medicine last week, showed positive potential for remdesivir as a treatment for COVID-19.
The randomized, controlled trial, sponsored by the National Institute of Allergy and... Read More »
Through its COVID-Local site, the Nuclear Threat Initiative (NTI) has released a guide of new metrics meant to guide local leaders and state officials in safely reopening the United States.
The site now includes interactive graphics and downloadable PDFs, meant to aid assessment of existing... Read More »
U.S. Food and Drug Administration (FDA) regulators have moved against dozens of supposed COVID-19 antibody tests that have never been shown to work, publishing a list of those that failed to file applications or have already pulled their products voluntarily.
There are 28 on that list so far,... Read More »
Two agencies are espousing the benefits of the Innovation Summit for Preparedness and Resilience (InSPIRE), which is dedicated to fostering policy and technology innovation for preparedness and resilience.
The summit was hosted by the Department of Homeland Security (DHS) Science and Technology... Read More »
AstraZeneca has reached first agreements for at least 400 million doses of a potential COVID-19 vaccine developed by the University of Oxford, including 300 million for the United States.
First shipments will begin rolling out to the U.K. in September, then the United States in October. The... Read More »
Lockheed Martin is adjusting work schedules, maintaining specialized employee skill sets, and accelerating payments to vulnerable suppliers in response to F-35 supplier delays due to COVID-19.
"These are challenging times, but managing tough challenges is when the F-35 program performs at its... Read More »
Mount Sinai Health System and Renalytix AI have formed Kantaro Biosciences, LLC, as a means of developing, producing, and distributing a COVID-19 testing kit based on Mount Sinai’s high-performance serologic assay for antibodies.
The test kits hunt for SARS-CoV-2 antibodies and are usable in... Read More »
National Fraternal Order of Police (FOP) personnel said the organization has united with AT&T to educate officers nationwide regarding the benefits of FirstNet, the public safety communications platform.
The initiative involves providing insight on the impact FirstNet can have on public safety... Read More »
A pair of Lawrence Livermore National Laboratory (LLNL) researchers are part of a three-institution team funded by the Defense Threat Reduction Agency (DTRA) to further develop a tularemia vaccine.
Nick Fischer and Amy Rasley will collaborate with University of New Mexico and Tulane National... Read More »
National Institutes of Health (NIH) Director Francis Collins co-wrote an article in the Journal of the American Medical Association (JAMA) that a swift, coordinated effort across many sectors of society is necessary to respond to the COVID-19 pandemic.
The article – co-written by Collins and... Read More »
With an underwritten public offering of $1.25 billion in shares of common stock, Moderna, Inc. hopes to entice buyers to raise funds for the manufacturing of mRNA-1273, the company’s vaccine candidate for use on SARS-CoV-2 -- the virus responsible for COVID-19.
Additionally, underwriters will... Read More »
In an effort to counter potential medical shortages, the United States federal government has awarded $354 million to the Phlow Corporation, with an eye on advanced manufacturing of essential medicines.
In all, that contract could stretch up to $812 million, thanks to a four-year base award of... Read More »
The Association of State and Territorial Health Officials (ASTHO) and National Coalition of STD Directors (NCSD) said the agencies have trained over 10,000 individuals nationwide in COVID-19 contact tracing.
The effort seeks to support ongoing state and local public health agencies in preparing... Read More »
The Trump administration appointed last week Dr. Moncef Slaoui and U.S. Army General Gustave F. Perna to lead the advancement of Operation Warp Speed, a program to accelerate the development, manufacturing, and distribution of COVID-19 medical countermeasures.
Slaoui, a former Chairman of both... Read More »
Research conducted last month by scientists from the National Institutes of Health and the University of Oxford showed promise for the investigational SARS-CoV-2 vaccine, ChAdOx1 nCoV-19, at least when used on rhesus macaques.
The vaccine, which was created by the University of Oxford Jenner... Read More »
The leaders of Costa Rica and Chile, working with the World Health Organization (WHO), are spearheading an effort to create a technology platform that aims to lift access barriers to effective vaccines, medicines, and other health products against COVID-19.
“Our proposal relies on... Read More »
Security screening firm Smiths Detection has introduced an ultraviolet (UVC) light kit it maintains is capable of destroying up to 99.9 percent of microorganisms present at airport security checkpoints.
Smiths Detection UVC kits automatically disinfect baggage trays as they are being transported... Read More »
Boeing has secured a combined $3.1 billion Navy contract for Harpoon and Standoff Land Attack Missile Expanded Response (SLAM ER) weapon systems in support of Foreign Military Sales (FMS).
Officials indicated about $2.6 billion of the agreement was recently contracted, with the remainder having... Read More »
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) recently awarded up to $6.2 million to the infectious disease diagnostics firm Day Zero Diagnostics to accelerate early research of and develop treatments for superbug infections.
“There has never been a more... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) announced an additional $384 million investment into Novavax Inc. this week, as a means of accelerating development and manufacture of its NVX-CoV2373 COVID-19 vaccine candidate.
This extends ongoing collaboration between the two... Read More »
While many vaccine and treatment prospects have been put forward for dealing with COVID-19, health experts from the National Institutes of Health (NIH) have advised in a new Science-published paper that a collaborative strategy for testing, scale-up, and distribution of candidates is... Read More »
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for its COVID-19 laboratory developed test (LDT).
The action allows the testing of samples self-collected by patients at home using the Spectrum Solutions LLC... Read More »
Under a plan finalized on May 3, 607,000 vials of the drug remdesivir were donated for use in United States hospitals hosting COVID-19 patients by the drug’s creator, Gilead Sciences, Inc.
These shipments began to roll out on May 7, packed into cases and dispatched to Connecticut (30 cases),... Read More »
The United States’ preparedness and response capabilities have buckled under the stress of the ongoing COVID-19 pandemic and proactive work is needed to meet the next infectious disease before it strikes, said experts during the Bipartisan Commission on Biodefense May 8 virtual... Read More »
Industrial technology firm FLIR Systems has secured a $20.6 million Army contract to deliver Black Hornet 3 Personal Reconnaissance Systems in support of surveillance capabilities.
“Black Hornet has proven to be a game-changing technology – a small package that can deliver a big edge on the... Read More »
Researchers at the Lawrence Livermore National Laboratory (LLNL) have developed smart, breathable fabric designed to protect against biological and chemical warfare agents.
The material could be used by healthcare workers and first responders in clinical and medical settings as well as military... Read More »
Representatives from private industry and the federal government have joined forces to combat fraud and other illegal activity surrounding the COVID-19 pandemic.
The U.S. Homeland Security Investigations National Intellectual Property Rights Coordination Center (IPR Center) is working with... Read More »
